<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01530685</url>
  </required_header>
  <id_info>
    <org_study_id>PILEJE-Glyca-0910</org_study_id>
    <nct_id>NCT01530685</nct_id>
  </id_info>
  <brief_title>Gycabiane and Glycemic Control of Prediabetic Subjects</brief_title>
  <official_title>Effect of Glycabiane, a Dietary Supplement, on Glycemic Control of Prediabetic Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pileje</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pileje</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effects of supplementation Glycabiane, a dietary
      supplement, on glycemic control of overweight prediabetic subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cinnamon's effects on blood glucose have been the subject of many clinical and animal
      studies; however, the issue of cinnamon intake's effect on fasting blood glucose (FBG) in
      people with prediabetes still remains unclear.

      The main purpose of this study is to examine the effects of supplementation with Glycabiane,
      a dietary supplement rich in cinnamon extract, on fast blood glucose of overweight
      prediabetic subjects in a randomized, placebo-controlled, clinical trial.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">August 2012</completion_date>
  <primary_completion_date type="Anticipated">April 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fast Blood Glucose</measure>
    <time_frame>4 months</time_frame>
    <description>Fast blood glucose will be measured before and after 4 months of supplementation and after 2 months of wash-out</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hyperglycemia</condition>
  <arm_group>
    <arm_group_label>Glycabiane, gelule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Glycabiane</intervention_name>
    <description>2 gelule per day for 4 months</description>
    <arm_group_label>Glycabiane, gelule</arm_group_label>
    <other_name>Dietary supplement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>2 gelules per day for 4 months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female from 25 to 65 years old

          -  1.0g/L ≤ fast blood glucose &lt; 1.26g/L

          -  overweight (IMC &gt; 25)

        Exclusion Criteria:

          -  thyroid disease

          -  hypogonadism

          -  History of musculoskeletal, autoimmune or neurological disease

          -  Treatment against thyroid disease, hypoglycemia, hypertension, or anti-coagulant

          -  Pregnant or lactating women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karine Clément, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>INSERM U872</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karine Clément, Pr</last_name>
    <phone>+33 1 42 17 79 19</phone>
    <email>karine.clement@psl.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Pitié Salpetriere</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salwa Rizkalla, Dr</last_name>
      <phone>+33 1 42 17 79 81</phone>
      <email>salwa.rizkalla@psl.aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2011</study_first_submitted>
  <study_first_submitted_qc>February 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2012</study_first_posted>
  <last_update_submitted>February 9, 2012</last_update_submitted>
  <last_update_submitted_qc>February 9, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cinnamon</keyword>
  <keyword>chromium</keyword>
  <keyword>prediabete</keyword>
  <keyword>overweight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

